Day One Biopharmaceuticals (DAWN) Earnings Date, Estimates & Call Transcripts $12.69 -0.10 (-0.78%) (As of 12/23/2024 05:26 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Day One Biopharmaceuticals Latest Earnings SummaryActual EPS (Oct. 30) $0.38 Beat By $0.58 Consensus EPS (Oct. 30) -$0.20 Day One Biopharmaceuticals released Q3 2024 earnings on October 30, 2024, reporting an EPS of $0.38, which beat the consensus estimate of -$0.20 by $0.58. Quarterly revenue was reported to be $93.76 million, above the consensus estimate of $15.05 million. With a trailing EPS of -$1.03, Day One Biopharmaceuticals' earnings are expected to decrease next year, from ($0.88) to ($0.99) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by Get Day One Biopharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Day One Biopharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDAWN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DAWN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Day One Biopharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.71-$0.66-$0.68Q2 20243-$0.77-$0.67-$0.73Q3 20243-$0.73$0.11-$0.44Q4 20243-$0.73-$0.35-$0.60FY 202412-$2.94-$1.57-$2.46Q1 20252-$0.34-$0.29-$0.32Q2 20252-$0.29-$0.21-$0.25Q3 20252-$0.23-$0.18-$0.21Q4 20252-$0.20-$0.10-$0.15FY 20258($1.06)($0.78)($0.92) Day One Biopharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/30/2024Q3 2024-$0.20$0.38+$0.58$0.38$15.05M$93.76M7/30/2024Q2 2024-$0.75-$0.05+$0.70-$0.05$0.90M$8.19M5/6/2024Q1 2024-$0.67-$0.72 -$0.05-$0.72--2/26/2024Q4 2023-$0.57-$0.64 -$0.07-$0.64--11/6/2023Q3 2023-$0.60-$0.54+$0.06-$0.54--8/7/2023Q2 2023-$0.60-$0.61 -$0.01-$0.61--Six Stocks That Could Soar on Trump’s First Day Back (Ad)The recent election results have clarified a path forward, creating opportunities that weren't as clear just months ago. Louis has identified six specific AI stocks that are poised to benefit from this.Click here to learn which AI companies Louis believes will dominate the market... 5/1/2023Q1 2023-$0.59-$0.59--$0.59--3/6/2023Q4 2022-$0.57-$0.56+$0.01-$0.56-- Day One Biopharmaceuticals Earnings - Frequently Asked Questions When did Day One Biopharmaceuticals announce their last quarterly earnings? Day One Biopharmaceuticals (NASDAQ:DAWN) last announced its quarterly earning data on Wednesday, October 30, 2024. Learn more on DAWN's earnings history. Did Day One Biopharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Day One Biopharmaceuticals (NASDAQ:DAWN) reported $0.38 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.58. Learn more on analysts' earnings estimate vs. DAWN's actual earnings. How can I listen to Day One Biopharmaceuticals's earnings conference call? The conference call for Day One Biopharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Day One Biopharmaceuticals's conference call transcript? The conference call transcript for Day One Biopharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Day One Biopharmaceuticals generate each year? Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded annual revenue of $101.95 million. How much profit does Day One Biopharmaceuticals generate each year? Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded net income of -$188.92 million. DAWN has generated -$1.03 earnings per share over the last four quarters. What is Day One Biopharmaceuticals's EPS forecast for next year? Day One Biopharmaceuticals's earnings are expected to decrease from ($0.88) per share to ($0.99) per share in the next year. More Earnings Resources from MarketBeat Related Companies TGTX Earnings Date CRNX Earnings Date VKTX Earnings Date KRYS Earnings Date ADMA Earnings Date ACLX Earnings Date APLS Earnings Date SRRK Earnings Date RARE Earnings Date IMVT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Six Stocks That Could Soar on Trump’s First Day Back (Ad)The recent election results have clarified a path forward, creating opportunities that weren't as clear just months ago. Louis has identified six specific AI stocks that are poised to benefit from this.Click here to learn which AI companies Louis believes will dominate the market... This page (NASDAQ:DAWN) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DAWN Stock Alerts